News ALZpath licenses Alzheimer’s diagnosis tech to Roche Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.
News Trial raises hopes for simple Alzheimer’s blood test Testing a person’s blood for a protein called phosphorylated tau could provide a means of large-scale screening for Alzheimer’s disease (AD), according to a new study.
Digital AI-powered drug discovery is outpacing regulators, with Eric... During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
